Share Name Share Symbol Market Type Share ISIN Share Description
Sinclair Pharma LSE:SPH London Ordinary Share GB0033856740 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.30p -1.54% 19.125p 96,742 16:35:27
Bid Price Offer Price High Price Low Price Open Price
18.50p 19.75p 19.10p 18.50p 19.10p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 45.30 -4.34 -0.01 96.3

Sinclair Pharma (SPH) Latest News (1)

More Sinclair Pharma News
Sinclair Pharma Takeover Rumours

Sinclair Pharma (SPH) Share Charts

1 Year Sinclair Pharma Chart

1 Year Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

Intraday Sinclair Pharma Chart

Intraday Sinclair Pharma Chart

Sinclair Pharma (SPH) Discussions and Chat

Sinclair Pharma Forums and Chat

Date Time Title Posts
17/8/201814:07Sinclair Pharma Thread1,954
15/10/201415:32TipTV: Sinclair Pharmaceuticals to head back towards 30p!-
21/2/200508:49Small cap Sinclair Pharma - Walmart inc.-

Add a New Thread

Sinclair Pharma (SPH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Sinclair Pharma trades in real-time

Sinclair Pharma (SPH) Top Chat Posts

Sinclair Pharma Daily Update: Sinclair Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SPH. The last closing price for Sinclair Pharma was 19.43p.
Sinclair Pharma has a 4 week average price of 18.50p and a 12 week average price of 14.75p.
The 1 year high share price is 30p while the 1 year low share price is currently 14.45p.
There are currently 503,768,952 shares in issue and the average daily traded volume is 494,925 shares. The market capitalisation of Sinclair Pharma is £96,345,812.07.
steeplejack: Very true,Tosca won’t want to sell out at a loss. The Chinese must of been aware from the very beginning that the agreement of Tosca was a prerequisite of a successful bid.Remember this statement made in early July- “HMC is a leading Chinese pharmaceutical manufacturer and distributor, and is also one of the largest aesthetic marketing companies in China offering botulinum toxin products and fillers. The company's strategy is to become one of the leading aesthetic companies worldwide and believes that Sinclair would support HMC in achieving this ambition. There can be no certainty that an offer will be made, nor as to the terms on which any offer might be made though HMC and CGE confirm that any offer is likely to be solely in cash.” So if the bid is likely to be made in cash,why is the share price going down?Frankly I can’t see our esteemed shareholder list accepting 20p.Maybe the terms of any bid have subtly altered during discussions such that the Chinese might take a controlling interest but the existing major shareholders keep ‘skin’ in the game.The share price is saying that no bid will occur but the extensions of PUSU suggest otherwise.It’s opaque.
+eysenck: 2 days to and all is quiet. Share price movements are not preceding the news on this occasion.
dealit: "Mercer95, egg", since July 6th their as been 13 8.5 announcements and the share price as moved up and back down again, please tell me why??
steeplejack: Strikes me as a surly response to an ok set of results.It is of course likely that this share is rather badly researched and that share price reactions are mercurial.The trouble is the,the prospective PE rating has always been fairly generous.The company will have to put more meat on the bones as to why its decided to go it it alone on the distribution front.I don't have enough experience to know how radical a decision this is,but I suspect it might be a good deal more demanding than immediately seems apparent.
hashertu: The answer to the share price drop might be more prosaic. On March 1, Schroders dropped below 5% (which is 25 million shares). Some of these might have been held in the UK Growth Fund. Management of this fund has been transferred to Baillie Gifford who plan to run a "concentrated portfolio of about 40 of their best investment ideas" (source Investors Chronicle). I suspect BG are the sellers due to the change in investment direction, and not due to something lurking behind the woodshed.
steeplejack: All very encouraging..........what it irritates me is "the mystery" surrounding this persistent and relentless fall in price from the mid 30s.Have we been misled,has a wheel unexpectedly fallen off the wagon,has management exaggerated product prospects.Something's amiss and Monday will either confirm the reason for the share price slide or show it to be erroneous.Sadly,experience tells me to expect the former.
steeplejack: I think the share price is telling us that a deal is not going as smoothly as they would wish.Problems are being discounted and a resolution accompanied by reasonable figures should see a jump in the shares..........(wishful thinking :)
soundbuy: Hmmmm........remember the day SPH sold assets to APH......many thought APH had well over-paid, share price reacted badly and it looked as if SPH had pulled a blinder.......move on a couple of years and SPH languishing in the doldrums, burning through the proceeds with APH on the ascent, sweating those very same assets......
glynedwards: I was warned by a city friend to beware of calling the low point of any share price as "only chimpanzees pick bottoms" However.........
dealit: Encouraging share price rise today, maybe announcement on new distribution partnership is reason why share price has moved North today. IMHO the share price will slowly go upwards in anticipation of result statement next month.
Sinclair Pharma share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180820 04:59:23